CIK 0001815776
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 844867570
- Phone
- +1 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- 4 Open-market sale 10% owner sold 135,304 shares at an average $42.23 ($5,714,356)
- 4 Open-market sale 10% owner sold 188,094 shares at an average $39.47 ($7,423,920)
- 4 Open-market sale 10% owner sold 260,713 shares at an average $39.34 ($10,255,244)
- 4 Open-market sale 10% owner sold 191,376 shares at $34.00 ($6,506,784)
- 4 Open-market sale 10% owner sold 200,000 shares at $30.47 ($6,093,000)
- 4 Open-market sale 10% owner sold 334,801 shares at an average $30.19 ($10,107,818)
- 4 Open-market sale 10% owner sold 350,000 shares at $29.00 ($10,150,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Chief Commercial Officer acquired 1,400 shares (option exercise)
- 4 Option exercise President, CEO and Secretary acquired 4,200 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 7 · 129 filings